Nvidia has significantly expanded its role in the global AI ecosystem by pairing its dominance in GPUs with an aggressive investment strategy, closing at least 67 AI-related startup deals in 2025. Backed by surging revenue and a market capitalisation of roughly $4.6 trillion, the company has deployed capital across foundation models, infrastructure, robotics, and healthcare. Among these investments is support for Hippocratic AI, reflecting Nvidia’s interest in AI applications that address real-world challenges such as healthcare workforce shortages and scalable patient engagement. These investments often align with long-term adoption of Nvidia hardware, reinforcing its position at the center of AI development.
Within healthcare specifically, Nvidia’s backing of Hippocratic AI highlights growing confidence in healthcare-focused large language models designed for safe, patient-facing use cases. This support places Hippocratic AI alongside other high-profile AI companies benefiting from Nvidia’s ecosystem, which combines capital, compute, and infrastructure to accelerate deployment. As Nvidia continues to invest across the AI stack, its involvement provides Hippocratic AI with both validation and access to the computational resources needed to scale, underscoring positive momentum for healthcare-oriented AI solutions within the broader industry expansion.